Literature DB >> 7725228

Intraepithelial sebaceous neoplasia without underlying invasive carcinoma.

C E Margo1, H E Grossniklaus.   

Abstract

Two patients with intraepithelial sebaceous neoplasia of the conjunctiva and cornea without an underlying invasive carcinoma are described. This intraepithelial disease displays the same cytologic features found in the conjunctival epithelium of patients with an invasive sebaceous carcinoma. The natural history of this incipient carcinoma is unknown. Anecdotal evidence indicates that some lesions can remain in situ for prolonged periods without undergoing transformation to an invasive carcinoma. The diagnosis of intraepithelial sebaceous neoplasia of the ocular surface is established by excluding an occult invasive carcinoma with appropriate biopsies.

Entities:  

Mesh:

Year:  1995        PMID: 7725228     DOI: 10.1016/s0039-6257(05)80106-7

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

1.  Primary sebaceous carcinoma of the corneaoscleral limbus with pagetoid recurrence.

Authors:  Sang Jun Park; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Korean J Ophthalmol       Date:  2009-06-09

2.  Villous Sebaceous Adenoma Arising from the Caruncular Surface Squamous Epithelium.

Authors:  Frederick A Jakobiec; Paula Cortes Barrantes; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-03-10

3.  Primary sebaceous gland carcinoma of the bulbar conjunctiva without involvement of eyelid: A clinical dilemma.

Authors:  Kalpana Pandey; Parul Singh; Abhishek Singh; Harishanker Pandey
Journal:  Oman J Ophthalmol       Date:  2011-05

4.  Isolated primary sebaceous gland carcinoma of the bulbar conjunctiva.

Authors:  Kenneth Chang; Justin M Wileman; Ryan D Gabbard; Ryan J Woodard; Rakesh M Patel; Shawn M Iverson
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-31

Review 5.  Update on conjunctival pathology.

Authors:  Hardeep Singh Mudhar
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.